Comparison of AIMS65 Score and Other Scoring Systems for Predicting Clinical Outcomes in Koreans with Nonvariceal Upper Gastrointestinal Bleeding
2
조회
0
다운로드
5
인용
0
참고문헌
키워드
초록
Background/Aims: The AIMS65 score has not been sufficiently validated in Korea. The objective of this study was to compare the AIMS65 and other scoring systems for the prediction of various clinical outcomes in Korean patients with acute nonvariceal upper gastrointestinal bleeding (NVUGIB). Methods: The AIMS65 score, clinical and full Rockall scores (cRS and fRS) and Glasgow-Blatchford (GBS) score were calculated in patients with NVUGIB in a single center retrospectively. The performance of these scores for predicting mortality, rebleeding, transfusion requirement, and endoscopic intervention was assessed by calculating the area under the receiver-operating characteristic curve. Results: Of the 523 patients, 3.4% died within 30 days, 2.5% experienced rebleeding, 40.0% required endoscopic intervention, and 75.7% needed transfusion. The AIMS65 score was useful for predicting the 30-day mortality, the need for endoscopic intervention and for transfusion. The fRS was superior to the AIMS65, GBS, and cRS for predicting endoscopic intervention and the GBS was superior to the AIMS65, fRS, and cRS for predicting the transfusion requirement. Conclusions: The AIMS65 score was useful for predicting the 30-day mortality, transfusion requirement, and endoscopic intervention in Korean patients with acute NVUGIB. However, it was inferior to the GBS and fRS for predicting the transfusion requirement and endoscopic intervention, respectively.
Abstract
Background/Aims: The AIMS65 score has not been sufficiently validated in Korea. The objective of this study was to compare the AIMS65 and other scoring systems for the prediction of various clinical outcomes in Korean patients with acute nonvariceal upper gastrointestinal bleeding (NVUGIB). Methods: The AIMS65 score, clinical and full Rockall scores (cRS and fRS) and Glasgow-Blatchford (GBS) score were calculated in patients with NVUGIB in a single center retrospectively. The performance of these scores for predicting mortality, rebleeding, transfusion requirement, and endoscopic intervention was assessed by calculating the area under the receiver-operating characteristic curve. Results: Of the 523 patients, 3.4% died within 30 days, 2.5% experienced rebleeding, 40.0% required endoscopic intervention, and 75.7% needed transfusion. The AIMS65 score was useful for predicting the 30-day mortality, the need for endoscopic intervention and for transfusion. The fRS was superior to the AIMS65, GBS, and cRS for predicting endoscopic intervention and the GBS was superior to the AIMS65, fRS, and cRS for predicting the transfusion requirement. Conclusions: The AIMS65 score was useful for predicting the 30-day mortality, transfusion requirement, and endoscopic intervention in Korean patients with acute NVUGIB. However, it was inferior to the GBS and fRS for predicting the transfusion requirement and endoscopic intervention, respectively.
참고문헌 (17)
- Lewis JD, "Hospitalization and mortality rates from peptic ulcer disease and GI bleeding in the 1990s: relationship to sales of nonsteroidal antiinflammatory drugs and acid suppression medications", Am J Gastroenterol, 97, pp.2540~2549 (2002)
- Jutabha R, "Management of upper gastrointestinal bleeding in the patient with chronic liver disease", Med Clin North Am, 80, pp.1035~1068 (1996)
- Boonpongmanee S, "The frequency of peptic ulcer as a cause of upper-GI bleeding is exaggerated", Gastrointest Endosc, 59, pp.788~794 (2004)
- Laine L, "Management of patients with ulcer bleeding", Am J Gastroenterol, 107, pp.345~360 (2012)
- Barkun AN, "International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding", Ann Intern Med, 152, pp.101~113 (2010)
- Laursen SB, "The Glasgow Blatchford score is the most accurate assessment of patients with upper gastrointestinal hemorrhage", Clin Gastroenterol Hepatol, 10(e1), pp.1130~1135 (2012)
- Chen IC, "Risk scoring systems to predict need for clinical intervention for patients with nonvariceal upper gastrointestinal tract bleeding", Am J Emerg Med, 25, pp.774~779 (2007)
- Stanley AJ, "Multicentre comparison of the Glasgow Blatchford and Rockall Scores in the prediction of clinical end-points after upper gastrointestinal haemorrhage", Aliment Pharmacol Ther, 34, pp.470~475 (2011)
- Pang SH, "Comparing the Blatchford and pre-endoscopic Rockall score in predicting the need for endoscopic therapy in patients with upper GI hemorrhage", Gastrointest Endosc, 71, pp.1134~1140 (2010)
- Stanley AJ, "Outpatient management of patients with low-risk upper-gastrointestinal haemorrhage: multicentre validation and prospective evaluation", Lancet, 373, pp.42~47 (2009)
- Bryant RV, "Performance of the Glasgow-Blatchford score in predicting clinical outcomes and intervention in hospitalized patients with upper GI bleeding", Gastrointest Endosc, 78, pp.576~583 (2013)
- Gralnek IM, "Incremental value of upper endoscopy for triage of patients with acute non-variceal upper-GI hemorrhage", Gastrointest Endosc, 60, pp.9~14 (2004)
- Chandra S, "External validation of the Glasgow-Blatchford bleeding score and the Rockall score in the US setting", Am J Emerg Med, 30, pp.673~679 (2012)
- Saltzman JR, "A simple risk score accurately predicts in-hospital mortality, length of stay, and cost in acute upper GI bleeding", Gastrointest Endosc, 74, pp.1215~1224 (2011)
- Hyett BH, "The AIMS65 score compared with the Glasgow-Blatchford score in predicting outcomes in upper GI bleeding", Gastrointest Endosc, 77, pp.551~557 (2013)
- Jung SH, "Is the AIMS65 score useful in predicting outcomes in peptic ulcer bleeding?", World J Gastroenterol, 20, pp.1846~1851 (2014)
- Yaka E, "Comparison of the Glasgow-Blatchford and AIMS65 scoring systems for risk stratification in upper gastrointestinal bleeding in the emergency department", Acad Emerg Med, 22, pp.22~30 (2015)